Domov › Adenokarcinom požiralnika › North Carolina
Klinične študije za Adenokarcinom požiralnika v North Carolina
12 študij za Adenokarcinom požiralnika išče udeležence na lokacijah v North Carolina.
Mesta v North Carolina
Uradno besedilo študije (angleško)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- Southeastern Medical Oncology Center-Clinton, Clinton
- in še 6
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- University of North Carolina Medical Center, Chapel Hill
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
- Duke University Medical Center, Durham
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07603375Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University of North Carolina at Chapel Hill, Chapel Hill
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 50 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of North Carolina School of Medicine, Chapel Hill
Vključevanje udeležencev
Starost 18–89 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Charlotte
- Research Site, Wilmington
- Research Site, Winston-Salem
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07431281Obeticholic Acid for Prevention in Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT04939051Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- University of North Carolina at Chapel Hill, Chapel Hill
Vključevanje udeležencev
Starost 18–89 · Vsi spoli · Posodobljeno 1. jul. 2026 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Durham
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT07284186A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- Durham VA Medical Center, Durham, NC, Durham
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. nov. 2025 · NCT05563766Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.